logo
Bacardi-Owned BOMBAY SAPPHIRE(R) Announces 'Electrifying' Global Partnership With E1 Series

Bacardi-Owned BOMBAY SAPPHIRE(R) Announces 'Electrifying' Global Partnership With E1 Series

Yahoo14-05-2025
BOMBAY SAPPHIRE invites the world to 'Step Into The Blue™' as it joins E1, the world's first all-electric power boat racing Championship, as Official Gin Partner of the UIM E1 World Championship - a global spectacle backed by some of the biggest names in sport and entertainment
HAMILTON, BM / / May 14, 2025 / Bacardi-owned BOMBAY SAPPHIRE® is stepping into the world of sports entertainment, announcing a new global partnership with E1 Series - the world's first all-electric race boat Championship that combines sports, entertainment and a respect for the world's 'natural blues.'
The partnership sees BOMBAY SAPPHIRE become the Official Gin Partner of the UIM E1 World Championship. BOMBAY SAPPHIRE branding will appear across the Championship, with teams backed by some of the biggest names in sports and entertainment, including Marc Anthony, Steve Aoki, LeBron James, Virat Kohli, Rafa Nadal and Will Smith.
Each E1 team competes with one male and one female pilot who are drawn from the worlds of motorsport and power boat racing. Beyond the racing, teams actively engage with the local communities the series races in to promote efforts to regenerate the world's oceans and aquatic ecosystems.
Natasha Curtin, Global VP at BOMBAY SAPPHIRE, comments: "This partnership between BOMBAY SAPPHIRE and E1 is a bold new chapter in our global journey - and brings our 'Step Into The Blue' campaign to life on an electrifying, international stage. We're proud to join forces with E1 to celebrate innovation, sustainability, and the awe-inspiring beauty of the world's most breathtaking natural blues - while marking our first ever foray into global sports entertainment.
She continues: "Like BOMBAY SAPPHIRE, E1 is dedicated to inviting audiences to be part of immersive and inspiring moments - and unlocking a world of beautiful experiences that not only captivate but are also underpinned by a passion for showcasing the multisensorial beauty of the natural world."
With E1 driving change in marine mobility and sustainability, the two partners are united by a shared passion for cherishing the beauty of the natural world. BOMBAY SAPPHIRE will become the Presenting Partner of the E1 Series Blue Impact Championship, designed to protect nature's natural blues, and heal water and local ecosystems where the championship takes place.
As part of the Bacardi family of brands, protecting the planet is a priority for BOMBAY SAPPHIRE and has been for over 25 years. Crafted using a unique blend of 10 hand-selected botanicals from sustainably certified suppliers from around the world, BOMBAY SAPPHIRE is distilled at Laverstoke Mill in the south of England, using a signature vapour infusion process that gently extracts the botanicals' natural flavours, creating the vibrant and versatile taste that BOMBAY SAPPHIRE is known for.
When it opened its doors in 2014, the distillery's design was awarded "Outstanding" by BREEAM®, one of the world's leading environmental assessments for buildings, and in 2023, the site achieved Wildlife Habitat Council certification, recognising efforts to support local wildlife and biodiversity.
Rodi Basso, founder and CEO of E1, said: "Welcoming BOMBAY SAPPHIRE as a Championship partner solidifies E1's status as one of the most compelling commercial opportunities in global sport and entertainment. With celebrity star power, highly competitive racing, and a purpose to accelerate change, we're the sport of tomorrow that innovative brands are backing today.
"In E1, BOMBAY SAPPHIRE has found a natural home. It is a partnership that is built on a shared passion for sustainability and we're energised to deliver impactful change together as we redefine racing on water."
BOMBAY SAPPHIRE will also be the Official Cocktail of E1, serving up BOMBAY SAPPHIRE and tonics and BOMBAY SAPPHIRE Sparkling Lemon cocktails to invited guests of the Ocean Club, E1's exclusive hospitality offering.
The partnership is the first major activation from BOMBAY SAPPHIRE, since its just-launched Step Into The Blue, a new fully integrated global campaign that is being executed through-the-line. Step Into The Blue invites people to immerse themselves in a beautiful, blue world, and celebrates the brand's role in bringing the beauty of the moment to life.
For more information on the partnership and upcoming race events, visit E1 Series or follow @BombaySapphire.
For further information, please contact the BOMBAY SAPPHIRE global press office at Ogilvy bombaysapphireglobal@ogilvy.com
About BOMBAY SAPPHIRE®
Based on a recipe that dates back to 1761, BOMBAY SAPPHIRE is crafted using a unique blend of 10 hand-selected botanicals from sustainably certified suppliers from around the world. We distil our gin at Laverstoke Mill in the south of England and it's here that our signature vapour infusion process gently extracts the botanicals' natural flavours, creating the vibrant and versatile taste that BOMBAY SAPPHIRE is known for. When it opened its doors in 2014, our distillery's design was awarded "Outstanding" by BREEAM®, one of the world's leading environmental assessments for buildings, and in 2023, it achieved Wildlife Habitat Council certification, recognizing our efforts to support local wildlife and biodiversity.
This year BOMBAY SAPPHIRE is putting its iconic blue bottle front and centre with the launch of its new brand platform 'Step Into The Blue'. The global campaign invites people to immerse themselves in a beautiful, blue world, and celebrates the brand's role in bringing the beauty of the moment to life.
The BOMBAY SAPPHIRE brand has been part of the portfolio of Bacardi Limited, headquartered in Hamilton, Bermuda for more than 25 years. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited.
bombaysapphire.com@bombaysapphire@bombaysapphireuk
ENJOY BOMBAY SAPPHIRE RESPONSIBLY BOMBAY SAPPHIRE, ITS TRADE DRESS AND STEP INTO THE BLUE ARE TRADEMARKS.
About the UIM E1 World Championship
E1 is the world's first and only all-electric raceboat championship sanctioned by the Union Internationale Motonautique (UIM), the international governing body for powerboating activities. The UIM E1 World Championship was established to create a new, exciting and competitive on-water racing Championship using electric technologies to focus efforts on innovations that help protect and restore our urban waters and coastal areas.
The Championship sees teams featuring both a male and female pilot. Racing on the water in iconic cities around the world including Jeddah, Doha, Monaco, and Miami, teams are owned by some of the biggest names on the planet. These already include LeBron James, Will Smith, Marc Anthony and Steve Aoki from the world of entertainment, Rafael Nadal, Tom Brady, Virat Kohli and Didier Drogba from the world of sport and Marcelo Claure from the world of business.
E1 pilots navigate tight and technical circuits behind the wheel of the electric E1 RaceBirds. For the latest news and updates, follow us at @E1Series on Facebook, X and Instagram. #ChampionsOfTheWater
https://www.e1series.com/
View additional multimedia and more ESG storytelling from Bacardi-Martini, Inc. on 3blmedia.com.
Contact Info:Spokesperson: Bacardi-Martini, Inc.Website: https://www.3blmedia.com/profiles/bacardi-limited Email: info@3blmedia.com
SOURCE: Bacardi-Martini, Inc.
View the original press release on ACCESS Newswire
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MRNA Earnings: Moderna Stock Slumps 10% on Lower Covid Vaccine Demand
MRNA Earnings: Moderna Stock Slumps 10% on Lower Covid Vaccine Demand

Business Insider

timean hour ago

  • Business Insider

MRNA Earnings: Moderna Stock Slumps 10% on Lower Covid Vaccine Demand

Shares in drug giant Moderna (MRNA) plummeted nearly 10% today after it reported a drop in Q2 sales. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The company reported earnings for the period of -$2.13, beating expectations of -$3.03 but also recorded a 41.1% drop in year-over-year sales to $142 million. However, that still beat forecasts of $128.3 million. Sentiment Hit Investor sentiment was also hit by the company dropping its revenue guidance for the full year to $1.85 billion at the midpoint from $2 billion, a 7.5% decrease. It blamed the 'timing of shipments.' The decline was primarily driven by lower Spikevax COVID vaccine sales, which totaled $114 million in the quarter. Moderna said demand is expected to be concentrated in the second half of the year, aligning with the fall and winter seasons as the vaccine continues to transition into a seasonal respiratory product. It also reported 'negligible' RSV vaccine mRESVIA® sales in the second quarter of 2025. The figures continue Moderna's difficult year in comparison with its peers – see below. 'In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine efficacy data and expanded our commercial portfolio with three new U.S. FDA approvals to drive future sales growth,' said Stéphane Bancel, Chief Executive Officer of Moderna. 'Looking forward, we have important catalysts over the next six months across our infectious disease and oncology programs that will help us deliver on the promise of our mRNA platform for patients.' Future Hopes This includes Intismeran autogene, a personalized cancer therapy which is being developed in collaboration with Merck (MRK). This includes two non-small cell lung cancer Phase 3 studies and Phase 2 studies for high-risk muscle invasive and high-risk non-muscle invasive bladder cancer. Cost of sales for 2025 is expected to be approximately $1.2 billion. Full-year 2025 research and development expenses are anticipated to be $3.6 to $3.8 billion, lowered from previous expectations of approximately $4.1 billion. Year-end cash and investments for 2025 are projected to be approximately $6 billion. Recently, Moderna announced an organizational restructuring that will reduce its global workforce by approximately 10%. The company anticipates a total headcount of less than 5,000 by the end of the year. Better news came today for the group after Pfizer (PFE) and its German partner BioNTech (BNTX) lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal.

Search Business Group Launches Generative SEO Services in Southern California to Help Healthcare Providers Dominate AI Search
Search Business Group Launches Generative SEO Services in Southern California to Help Healthcare Providers Dominate AI Search

Business Upturn

time6 hours ago

  • Business Upturn

Search Business Group Launches Generative SEO Services in Southern California to Help Healthcare Providers Dominate AI Search

Fullerton, CA, Aug. 01, 2025 (GLOBE NEWSWIRE) — Search Business Group, a Latino-owned digital marketing agency based in Southern California, announced the launch of its new Generative Engine Optimization (GEO) services to help doctors, dentists, and veterinary practices rank on AI-driven search platforms like ChatGPT, Perplexity, and Gemini. The new offering positions providers across the region to stay visible and competitive as patient search behavior shifts toward generative AI platforms. Ron Arellano, Founder and Creative Director of Search Business Group, leads healthcare marketing innovation with a focus on inclusivity, data-driven strategy, and digital visibility. The agency's healthcare-specific strategies have led to significant performance outcomes for practices across Orange County and beyond. One example includes New Generation Dentistry in Mission Viejo, which achieved a 300% increase in year-over-year revenue, a 60% increase in local search traffic, and a 70% rise in phone leads following a comprehensive campaign involving web development, SEO, and content optimization. Search Business Group is led by award-winning Creative Director Ron Arellano, whose background includes more than two decades of creative leadership across high-profile brands such as the NY Mets, T-Mobile, Bridgestone, and WeightWatchers. Under Arellano's direction, the agency has pivoted its expertise toward the healthcare sector, bringing global-level strategy to small and mid-sized practices. 'Doctors and specialists often lack access to custom marketing that reflects their unique voice and community,' said Arellano. 'Search Business Group fills that gap with culturally aware campaigns that produce real business results.' The agency has supported a wide range of providers—including orthodontists, oral surgeons, veterinary clinics, and med spas—by combining human-centered design with technical precision. Its approach emphasizes performance analytics, local SEO, and user-first content while also addressing representation and language equity in healthcare communications. As part of its forward-looking strategy, Search Business Group has also introduced Generative Engine Optimization (GEO) services to help healthcare providers rank in AI-driven search engines such as ChatGPT, Perplexity, and Gemini. This positions clients to stay visible and competitive as consumer search behavior continues to evolve. Search Business Group's foundation is rooted in both innovation and inclusion. As a first-generation immigrant from Ecuador, Arellano brings a cultural fluency that informs the agency's work across diverse markets. Search Business Group continues to expand its reach while prioritizing equity, trust, and growth in healthcare marketing. About Search Business Group Search Business Group is a Fullerton, California-based digital marketing agency specializing in healthcare, dental, and veterinary marketing. The Latino-owned firm offers services in SEO, web design, web development, content strategy, and generative search optimization, helping healthcare providers improve digital visibility and patient engagement through performance-driven, culturally informed solutions. Real Results: A 528% increase in online patient forms from January to July 2025, generating over $1.4 million in estimated revenue through digital strategy and local SEO. Press inquiries Search Business Group Bianca Montalvo [email protected] 714-519-6290 1316 North Placentia Ave. Fullerton, CA 92831

Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align's Common Stock
Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align's Common Stock

Business Wire

time7 hours ago

  • Business Wire

Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align's Common Stock

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ('Align') (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of Align's common stock. Since his last sale of Align common stock in 2021, Mr. Hogan has purchased approximately $8 million of Align common stock 1. 'This purchase reflects my continuing confidence in the long-term value of Align and our commitment to increasing shareholder value by balancing investments to drive growth and continuing to invest with discipline in the areas that will define our future,' said Joe Hogan, president and CEO. 'We are excited about our next-generation technologies and treatment platforms that meet today's patient expectations for fast, effective, and personalized treatment while also providing value and growth opportunities for our doctor customers. We believe that these innovations are not only improving outcomes in Invisalign practices but also expanding our addressable market and strengthening our competitive differentiation.' Continued Hogan, 'While we believe that the macroeconomic uncertainty will likely persist into the near future, we are confident in our ability to adapt and lead. Our long-term strategic initiatives and opportunities remain intact, as does our commitment to focused execution on transforming treatment for doctors and patients.' 1 Valued based on the purchase price of Align common stock at the time of each purchase. About Align Technology Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 286.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.8 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform, and iTero Lumina are trademarks of Align Technology, Inc.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store